|Articles|June 1, 2019
- Pharmaceutical Executive-06-01-2019
- Volume 39
- Issue 6
Pharmaceutical Executive, June 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's Top 50 Companies 2019about 7 years ago
The Argument for External Comparator Adoptionabout 7 years ago
Pharma Medical Affairs: A Blueprint for Futureabout 7 years ago
'Vision’ Quest: Leading Through Changeabout 7 years ago
Pharm Exec 50 Hints to Rest of ’19about 7 years ago
Predicting the Future of European Health Policyabout 7 years ago
A Critical Juncture for Antibiotic R&Dabout 7 years ago
New Strategies Sought to Pay for Costly Curesabout 7 years ago
Site Payments: Drilling in on Forecast, Budget Issuesabout 7 years ago
Building the Startup Dream TeamAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5